Novo Nordisk stock (NVO) jumped more than 2% in trading Wednesday after beating Wall Street's profit estimates for the first quarter and despite a slight cut to its sales forecast for the year.

He and the board are leading an evolution in the culture, but still very much doing things in ‘the Novo Nordisk way’ – which boils down to pursuing innovation with a Nordic attention to ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...

Alternative compounded versions of Novo Nordisk’s blockbuster weight-loss and diabetes drugs have hurt its sales, ...

Weight-loss drug maker Novo Nordisk reported an earnings beat, but sales fell short of expectations. Management gave an encouraging outlook for the rest of 2025. Novo Nordisk trades for less than ...

COPENHAGEN/LONDON, May 7 (Reuters) - Obesity drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it would drop gender representation requirements for senior leadership positions in ...

Novo Nordisk stock reported strong sales growth but lowered sales forecasts this morning. The good news: 2025 earnings will grow faster than sales. Novo Nordisk reports its results in Danish ...